Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Systemic scleroderma

Recruiting

Registered drug

Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Nemolizumab

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:SPY002

Contact Research Centre

Crohn's disease

Recruiting

Investigational

A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Crohn's disease

Recruiting

Investigational

A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:SPY002

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Hernia repair

Recruiting

Registered drugNo placebo

A Study of Botulinum Toxin Type A for Preparing the Abdominal Wall Before Surgery in Patients with Large Complex Hernias

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Botulinum Toxin Type A - Haemagglutinin Complex

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Transitional cell carcinoma

Recruiting

Registered drugNo placebo

Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you

36 trials match your criteria

Systemic scleroderma

Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

Colitis ulcerative

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Crohn's disease

A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease

Crohn's disease

A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease

Non-small cell lung cancer+1

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Colitis ulcerative

A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

Colitis ulcerative

A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

Colitis ulcerative

A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Colitis ulcerative

Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA

Hernia repair

A Study of Botulinum Toxin Type A for Preparing the Abdominal Wall Before Surgery in Patients with Large Complex Hernias

Plasma cell myeloma

Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

Transitional cell carcinoma

Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.